课题基金 / 基金详情

Transgenic mice : a unique model to reassess specific T cell suppression

Transgenic mice : a unique model to reassess specific T cell suppression
转基因小鼠:重新评估特异性 T 细胞抑制的独特模型
批准号:
nhmrc : 137841
负责人:
Dr Patrick Bertolino
金额:
$18.17万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2001
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2001-01-01 至 2003-12-31

项目摘要

项目成果

Dr Patrick Bertolino的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Acceptance of transplanted organs is currently achieved by treating the recipient with immunosuppressive drugs that block T cell responses. However, because these drugs are non-specific, they will block all T cell responses, including those directed to undesirable viral or bacterial infections. So, whilst this strategy is the best available at the moment, it is far from ideal. The best treatment would be to induce specific graft acceptance without immunosuppression. In the 1970 s several studies have described treatment of recipients achieving specific suppression mediated by a subset of T lymphocytes. Although the phenomenon can be observed, no consensus has been reached to explain the mechanisms involved in the different models. One reason was the unability to track a population of suppressive T cells. We have now the technology and more knowledge to reassess these studies and understand how specific suppression can be achieved. Our lab has developed transgenic mice to study these phenomenon. One of our transgenic models mimicks the T cell response following liver transplantation. Acceptance of liver transplants is more readily achieved than to other organ grafts, even across a major histocompatibility (MHC) barrier and without immunosuppressive drugs. Not only are liver transplants well accepted, but they may induce secondary acceptance of kidney or heart grafts from the same donor, which would otherwise be rejected. Although this property has been made use of by surgeons, the amazing capacity of the liver to be accepted and to induce acceptance of other organs is still not understood. Previous studies and our own model suggests that specific suppression is involved. Our model which enable us to track the relevant cells provides therefore a unique tool to understand how specific suppression can be achieved. Understanding these mechanisms would help us to design strategies to induce tolerance to any organ without immunosuppressing the patient.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inflammation, Angiogenesis and Cancer
  • 批准号:
    nhmrc : 571408
  • 项目类别:
    Programs
  • 资助金额:
    $551.22万
  • 财政年份:
    2009
  • 负责人:
    Dr Patrick Bertolino
  • 依托单位:
Role of hepatocytes in inducing primary CD8+ T cell activation and tolerance
  • 批准号:
    nhmrc : 115030
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $10.65万
  • 财政年份:
    2000
  • 负责人:
    Dr Patrick Bertolino
  • 依托单位:
国内基金
海外基金
脂滴聚集型小胶质细胞介导的髓鞘病变促进小鼠抑郁样行为及其机制研究
  • 批准号:
    82371528
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李媛
  • 依托单位:
孤独症动物模型(Fmr1 KO mice)脑功能网络的时空特性研究
  • 批准号:
    31171025
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    张晨
  • 依托单位:
MALT 淋巴瘤发病分子机理研究
  • 批准号:
    81071626
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2010
  • 负责人:
    张权庚
  • 依托单位:
肿瘤DNA低甲基化发生分子机理及其对白血病发病重要性的研究
  • 批准号:
    30872933
  • 项目类别:
    面上项目
  • 资助金额:
    36.0万元
  • 批准年份:
    2008
  • 负责人:
    张权庚
  • 依托单位: